The DOI matches its Crossref record.
Epidermal growth factor receptor pathway in central nervous system regenerative medicine: a narrative review
Abstract
The epidermal growth factor receptor (signaling pathway is involved in numerous important mammal cell functions, such as growth, survival, proliferation, and differentiation. Associated with this, it is involved in tissue normal development and growth, tumorigenesis, and in tissue repair. Epidermal growth factor receptor is broadly expressed in the organism, including in the central and peripheral nervous system, where it has important neurotrophic functions. The central nervous system has a limited capacity for regeneration upon lesion, leading to severe disabilities, such as blindness, sensorimotor deficits, and paralysis. However, observations suggest that its innate neurogenic response may be amplified to promote the replenishment of damaged neuronal populations. In addition, the environment can also be modulated to promote regeneration. Therefore, the pathways involved in neural tissue repair have been investigated in terms of regenerative medicine, to discover new therapies to recover from traumatic injury or ischemia in the central nervous system or to inhibit the progression of neurodegenerative diseases. Growth factors have been widely accepted as the most important promoters of proliferation and neurogenesis under physiologic conditions and after injury. In this review, we summarize how the epidermal growth factor receptor signaling pathway is involved in neuronal damage and neurodegeneration in several settings, including in the olfactory epithelium, brain, spinal cord, and optic nerve, where this pathway can be modulated in the context of regenerative medicine to promote neuronal regeneration and, therefore, neurological function reestablishment in response to insults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“M2-phenotype microglia were further subdivided into M2a, M2b, and M2c, which upregulate arginase-1 (Arg-1), interleukin 4 (IL-4), interleukin 10 (IL-10), and other anti-inflammatory and nutritional factors, contributing to neuroprotection and damage repair”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 69
- 2024, Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021, Lancet Neurol, 23, 344, 10.1016/S1474-4422(24)00038-3 · DOI · Paper page
- Romano, 2020, Role of EGFR in the nervous system, Cells, 9, 1887, 10.3390/cells9081887 · DOI · Paper page
- Robson, 2018, Impaired neural stem cell expansion and hypersensitivity to epileptic seizures in mice lacking the EGFR in the brain, FEBS J, 285, 3175, 10.1111/febs.14603 · DOI
- Tavassoly, 2020, Inhibition of brain epidermal growth factor receptor activation: a novel target in neurodegenerative diseases and brain injuries, Mol Pharmacol, 98, 13, 10.1124/mol.120.119909 · DOI
- Shaban, 2023, Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications, Cells, 13, 47, 10.3390/cells13010047 · DOI
- Kim, 2020, Role of heparin-binding epidermal growth factor-like growth factor in oxidative stress-associated metabolic diseases, Metab Syndr Relat Disord, 18, 186, 10.1089/met.2019.0120 · DOI
- Fang, 2023, The role of amphiregulin in ovarian function and disease, Cell Mol Life Sci, 80, 60, 10.1007/s00018-023-04709-8 · DOI
- Duffy, 2011, The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?, Clin Proteomics, 8, 9, 10.1186/1559-0275-8-9 · DOI · Paper page
- Taylor, 2014, Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways, Semin Cell Dev Biol, 28, 22, 10.1016/j.semcdb.2014.03.004 · DOI
- Rosenbaum, 2024, New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10), FEBS J, 291, 2733, 10.1111/febs.16870 · DOI
- Saad, 2024, The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond, FEBS J, 291, 10, 10.1111/febs.16923 · DOI
- Adrain, 2020, The complex life of rhomboid pseudoproteases, FEBS J, 287, 4261, 10.1111/febs.15548 · DOI
- Cavadas, 2017, Phosphorylation of iRhom2 controls stimulated proteolytic shedding by the metalloprotease ADAM17/TACE, Cell Rep, 21, 745, 10.1016/j.celrep.2017.09.074 · DOI
- Badenes, 2020, Deletion of iRhom2 protects against diet-induced obesity by increasing thermogenesis, Mol Metab, 31, 67, 10.1016/j.molmet.2019.10.006 · DOI
- Badenes, 2019, iRhom2 and TNF: Partners or enemies?, Sci Signal, 12, eaaz0444, 10.1126/scisignal.aaz0444 · DOI
- Oikonomidi, 2018, iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE, Elife, 7, e35032, 10.7554/eLife.35032 · DOI
- Badenes, 2023, The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth, Life Sci Alliance, 6, e202201644, 10.26508/lsa.202201644 · DOI
- Calligaris, 2021, Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution, Molecules, 26, 944, 10.3390/molecules26040944 · DOI
- Bleibaum, 2019, ADAM10 sheddase activation is controlled by cell membrane asymmetry, J Mol Cell Biol, 11, 979, 10.1093/jmcb/mjz008 · DOI
- Rosenkranz, 2020, Epidermal growth factor receptor: key to selective intracellular delivery, Biochemistry (Mosc), 85, 967, 10.1134/S0006297920090011 · DOI
- Gao, 2022, Restoring after central nervous system injuries: neural mechanisms and translational applications of motor recovery, Neurosci Bull, 38, 1569, 10.1007/s12264-022-00959-x · DOI
- Sireci, 2024, HB-EGF promotes progenitor cell proliferation and sensory neuron regeneration in the zebrafish olfactory epithelium, FEBS J, 291, 2098, 10.1111/febs.17033 · DOI
- Getchell, 2000, Horizontal basal cell proliferation in the olfactory epithelium of transforming growth factor-alpha transgenic mice, Cell Tissue Res, 299, 185
- Chen, 2020, Matrix metalloprotease-mediated cleavage of neural glial-related cell adhesion molecules activates quiescent olfactory stem cells via EGFR, Mol Cell Neurosci, 108, 103552, 10.1016/j.mcn.2020.103552 · DOI
- Adrain, 2024, Can the HB-EGF/EGFR pathway restore injured neurons?, FEBS J, 291, 2094, 10.1111/febs.17143 · DOI
- Scalabrino, 2022, Epidermal growth factor in the CNS: A beguiling journey from integrated cell biology to multiple sclerosis. an extensive translational overview, Cell Mol Neurobiol, 42, 891, 10.1007/s10571-020-00989-x · DOI
- Bielefeld, 2024, Traumatic brain injury promotes neurogenesis at the cost of astrogliogenesis in the adult hippocampus of male mice, Nat Commun, 15, 5222, 10.1038/s41467-024-49299-6 · DOI
- Chen, 2019, Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation, Sci Rep, 9, 2516, 10.1038/s41598-019-38676-7 · DOI
- Pastor-Alonso, 2024, HB-EGF activates EGFR to induce reactive neural stem cells in the mouse hippocampus after seizures, Life Sci Alliance, 7, e202201840, 10.26508/lsa.202201840 · DOI
- Yu, 2024, A novel network pharmacology strategy based on the universal effectiveness-common mechanism of medical herbs uncovers therapeutic targets in traumatic brain injury, Drug Des Devel Ther, 18, 1175, 10.2147/DDDT.S450895 · DOI
- Gómez-Oliva, 2023, Targeting epidermal growth factor receptor to recruit newly generated neuroblasts in cortical brain injuries, J Transl Med, 21, 867, 10.1186/s12967-023-04707-1 · DOI
- Sun, 2010, The effect of epidermal growth factor in the injured brain after trauma in rats, J Neurotrauma, 27, 923, 10.1089/neu.2009.1209 · DOI
- Teramoto, 2003, EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia, J Clin Invest, 111, 1125, 10.1172/JCI200317170 · DOI
- Ninomiya, 2006, Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone, Neurosci Lett, 403, 63, 10.1016/j.neulet.2006.04.039 · DOI
- Jurkowski, 2020, Beyond the hippocampus and the SVZ: adult neurogenesis throughout the brain, Front Cell Neurosci, 14, 576444, 10.3389/fncel.2020.576444 · DOI · Paper page
- Wang, 2023, Myricetin suppresses traumatic brain injury-induced inflammatory response via EGFR/AKT/STAT pathway, Sci Rep, 13, 22764, 10.1038/s41598-023-50144-x · DOI
- Solou, 2023, Management of neurological complications related to aneurysmal subarachnoid hemorrhage: A comparison of the bedside therapeutic algorithms, Surgeon, 21, e328, 10.1016/j.surge.2023.06.006 · DOI
- Nakano, 2023, Epidermal growth factor receptor mediates neuronal apoptosis after subarachnoid hemorrhage in mice, Stroke, 54, 1616, 10.1161/STROKEAHA.122.041977 · doi:10.1161/strokeaha.122.041977
- Suzuki, 2020, Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: Findings from basic and clinical studies, J Neurosci Res, 98, 42, 10.1002/jnr.24330 · DOI
- Shiba, 2014, Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats, Transl Stroke Res, 5, 238, 10.1007/s12975-014-0333-2 · DOI
- Fujimoto, 2016, Epidermal growth factor-like repeats of tenascin-C-induced constriction of cerebral arteries via activation of epidermal growth factor receptors in rats, Brain Res, 1642, 436, 10.1016/j.brainres.2016.04.034 · DOI
- Nakatsuka, 2017, Preventive effects of cilostazol against the development of shunt-dependent hydrocephalus after subarachnoid hemorrhage, J Neurosurg, 127, 319, 10.3171/2016.5.JNS152907 · DOI
- Peng, 2019, Activation of GPR30 with G1 attenuates neuronal apoptosis via src/EGFR/stat3 signaling pathway after subarachnoid hemorrhage in male rats, Exp Neurol, 320, 113008, 10.1016/j.expneurol.2019.113008 · DOI
- Nakano, 2019, Anti-vasospastic effects of epidermal growth factor receptor inhibitors after subarachnoid hemorrhage in mice, Mol Neurobiol, 56, 4730, 10.1007/s12035-018-1400-6 · DOI
- Li, 2021, Blocking the EGFR/p38/NF-κB signaling pathway alleviates disruption of BSCB and subsequent inflammation after spinal cord injury, Neurochem Int, 150, 105190, 10.1016/j.neuint.2021.105190 · DOI
- Tran, 2022, New insights into glial scar formation after spinal cord injury, Cell Tissue Res, 387, 319, 10.1007/s00441-021-03477-w · DOI · Paper page
- Li, 2014, Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury, J Neuroinflammation, 11, 71, 10.1186/1742-2094-11-71 · DOI
- Qu, 2012, Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury, J Neuroinflammation, 9, 178, 10.1186/1742-2094-9-178 · DOI · Paper page
- Piletsky, 2023, Modulation of EGFR activity by molecularly imprinted polymer nanoparticles targeting intracellular epitopes, Nano Lett, 23, 9677, 10.1021/acs.nanolett.3c01374 · DOI
- Ju, 2012, Induction of neuronal phenotypes from NG2+ glial progenitors by inhibiting epidermal growth factor receptor in mouse spinal cord injury, Glia, 60, 1801, 10.1002/glia.22398 · DOI
- Li, 2011, Inhibiting epidermal growth factor receptor attenuates reactive astrogliosis and improves functional outcome after spinal cord injury in rats, Neurochem Int, 58, 812, 10.1016/j.neuint.2011.03.007 · DOI
- Goldshmit, 2016, Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury, J Neurochem, 138, 845, 10.1111/jnc.13730 · DOI
- Xue, 2020, Epidermal growth factor receptor-extracellular-regulated kinase blockade upregulates TRIM32 signaling cascade and promotes neurogenesis after spinal cord injury, Stem Cells, 38, 118, 10.1002/stem.3097 · DOI
- Qin, 2024, Local delivery of EGFR, Bioact Mater, 33, 424
- Cigliola, 2023, Spinal cord repair is modulated by the neurogenic factor Hb-egf under direction of a regeneration-associated enhancer, Nat Commun, 14, 4857, 10.1038/s41467-023-40486-5 · DOI
- Zeng, 2023, The promising role of a zebrafish model employed in neural regeneration following a spinal cord injury, Int J Mol Sci, 24, 13938, 10.3390/ijms241813938 · DOI
- Jin, 2021, Blood-spinal cord barrier in spinal cord injury: a review, J Neurotrauma, 38, 1203, 10.1089/neu.2020.7413 · DOI · Paper page
- Liu, 2019, Vascular endothelial growth factor activates neural stem cells through epidermal growth factor receptor signal after spinal cord injury, CNS Neurosci Ther, 25, 375, 10.1111/cns.13056 · DOI
- Zheng, 2016, Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury, J Cell Mol Med, 20, 1062, 10.1111/jcmm.12761 · DOI
- Lv, 2024, EGFR-activated JAK2/STAT3 pathway confers neuroprotection in spinal cord ischemia-reperfusion injury: evidence from high-throughput sequencing and experimental models, Mol Neurobiol, 61, 646, 10.1007/s12035-023-03548-9 · DOI
- Lee, 2024, Optic nerve regeneration: Potential treatment approaches, Curr Opin Pharmacol, 74, 102428, 10.1016/j.coph.2023.102428 · DOI
- Fague, 2021, The basic science of optic nerve regeneration, Ann Transl Med, 9, 1276, 10.21037/atm-20-5351 · DOI
- Yang, 2021, Axon regeneration after optic nerve injury in rats can be improved via PirB knockdown in the retina, Cell Biosci, 11, 158, 10.1186/s13578-021-00670-w · DOI
- Zhu, 2023, Astrocytes in the optic nerve are heterogeneous in their reactivity to glaucomatous injury, Cells, 12, 2131, 10.3390/cells12172131 · DOI
- Liu, 2006, Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury, J Neurosci, 26, 7532, 10.1523/JNEUROSCI.1004-06.2006 · DOI · Paper page
- Liu, 2003, Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy, Neurobiol Dis, 13, 109, 10.1016/S0969-9961(03)00010-X · DOI
- Koprivica, 2005, EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans, Science, 310, 106, 10.1126/science.1115462 · DOI · Paper page
- Harder, 2017, Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective, Proc Natl Acad Sci U S A, 114, E3839, 10.1073/pnas.1608769114 · DOI
- Li, 2024, Kinase inhibitors and kinase-targeted cancer therapies: recent advances and future perspectives, Int J Mol Sci, 25, 5489, 10.3390/ijms25105489 · DOI
Cited by
Guo, Q., Wang, Y., Fu, M., Zhou, Z., Zhang, X., Chen, S., Xu, C., Wang, Y., & Wu, T. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102309 · Cited by 1
Metadata
- Authors
- Badenes, M.
- Affiliations
- Veterinary Medicine Research (I-MVET), Faculty of Veterinary Medicine, Lusófona University - Lisbon University Center, Lisbon, Portugal
- ORCID
- Badenes, Marina
- Venue
- Regenerative Medicine Reports
- Published
- 2024-12
- Volume
- 1
- Issue
- 2
- Pages
- 172-186
- ISSN
- 3050-6794
- 3050-6808
- Cited by
- 4
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidermal growth factor receptor pathway in central nervous system regenerative medicine: a narrative review. https://app.cochat.ai/papers/10.4103/regenmed.regenmed-d-24-00020
- The paper
- Badenes, M. (2024). Epidermal growth factor receptor pathway in central nervous system regenerative medicine: a narrative review. Regenerative Medicine Reports. https://doi.org/10.4103/regenmed.regenmed-d-24-00020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.